Epstein–Barr virus-related diffuse large B-cell lymphoma in mogamulizumab-treated adult T-cell leukemia with incomplete T-cell reconstitution

[1]  Y. Fujii,et al.  The perivascular microenvironment in Epstein–Barr virus positive primary central nervous system lymphoma: The role of programmed cell death 1 and programmed cell death ligand 1 , 2018, Neuropathology : official journal of the Japanese Society of Neuropathology.

[2]  K. Kamachi,et al.  Deep sequencing of the T cell receptor visualizes reconstitution of T cell immunity in mogamulizumab-treated adult T cell leukemia , 2018, Oncoimmunology.

[3]  Yoshio Suzuki,et al.  Development of Epstein-Barr Virus-related Primary Diffuse Large B-cell Lymphoma of the Central Nervous System in a Patient with Peripheral T-cell Lymphoma, Not Otherwise Specified after Mogamulizumab Treatment , 2017, Internal medicine.

[4]  Sudha Rao,et al.  Mechanisms Underlying T Cell Immunosenescence: Aging and Cytomegalovirus Infection , 2016, Front. Microbiol..

[5]  S. Fuji,et al.  Friend or foe? Mogamulizumab in allogeneic hematopoietic stem cell transplantation for adult T-cell leukemia/lymphoma. , 2016, Stem cell investigation.

[6]  R. Suzuki,et al.  A new high-throughput sequencing method for determining diversity and similarity of T cell receptor (TCR) α and β repertoires and identifying potential new invariant TCR α chains , 2016, BMC Immunology.

[7]  H. Ureshino,et al.  Effector Regulatory T Cells Reflect the Equilibrium between Antitumor Immunity and Autoimmunity in Adult T-cell Leukemia , 2016, Cancer Immunology Research.

[8]  K. Young,et al.  CME Information: EBV-positive diffuse large B-cell lymphoma of the elderly: 2016 update on diagnosis, risk-stratification and management , 2016 .

[9]  A. Hashimoto,et al.  Incidence of Malignancy and the Risk of Lymphoma in Japanese Patients with Rheumatoid Arthritis Compared to the General Population , 2015, The Journal of Rheumatology.

[10]  S. Iida,et al.  Reactivation of hepatitis B virus (HBV) infection in adult T-cell leukemia–lymphoma patients with resolved HBV infection following systemic chemotherapy , 2015, International Journal of Hematology.

[11]  Olga V. Britanova,et al.  Age-Related Decrease in TCR Repertoire Diversity Measured with Deep and Normalized Sequence Profiling , 2014, The Journal of Immunology.

[12]  Y. Maeda,et al.  Induction of molecular remission by using anti-CC-chemokine receptor 4 (anti-CCR4) antibodies for adult T cell leukemia: a risk of opportunistic infection after treatment with anti-CCR4 antibodies , 2013, Annals of Hematology.

[13]  R. Ueda,et al.  Defucosylated anti-CCR4 monoclonal antibody (KW-0761) for relapsed adult T-cell leukemia-lymphoma: a multicenter phase II study. , 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[14]  T. Todaka,et al.  Epstein–Barr virus‐associated primary central nervous system lymphoma in a patient with adult T‐cell leukemia / lymphoma , 2011, The Journal of dermatology.

[15]  J. Castillo,et al.  Infectious Agents and Cancer Open Access Ebv-positive Diffuse Large B-cell Lymphoma in a Human T-lymphotropic Virus Type 1 Carrier , 2009 .

[16]  Mushtaq Ahmed,et al.  Age-associated decline in T cell repertoire diversity leads to holes in the repertoire and impaired immunity to influenza virus , 2008, The Journal of experimental medicine.

[17]  Anne-Mieke Vandamme,et al.  Human T-lymphotropic virus 1: recent knowledge about an ancient infection. , 2007, The Lancet. Infectious diseases.

[18]  K. Sugamura,et al.  Regulatory T cell-like activity of Foxp3+ adult T cell leukemia cells. , 2006, International immunology.

[19]  D. Douek,et al.  A broad T-cell repertoire diversity and an efficient thymic function indicate a favorable long-term immune reconstitution after cord blood stem cell transplantation. , 2002, Blood.

[20]  M. Matsuoka,et al.  Impaired production of naive T lymphocytes in human T-cell leukemia virus type I-infected individuals: its implications in the immunodeficient state. , 2001, Blood.

[21]  T. Manabe,et al.  Epstein‐Barr virus‐associated Hodgkin's disease in HTLV‐I seropositive patients: A report of two cases , 1998, Pathology international.

[22]  H. Ikeda,et al.  Cerebral mass lesions associated with adult T-cell leukemia/lymphoma. , 1995, International journal of hematology.

[23]  H. Hurwitz,et al.  Lymphoma developing in a patient with rheumatoid arthritis taking low dose weekly methotrexate. , 1991, The Journal of rheumatology.

[24]  Y. Matsuno,et al.  Epstein-Barr virus (EBV) genome carrying monoclonal B-cell lymphoma in a patient with adult T-cell leukemia-lymphoma. , 1991, Leukemia research.

[25]  K. Akashi,et al.  Central nervous system involvement in adult T‐cell leukemia/lymphoma , 1990, Cancer.

[26]  Y. Hinuma,et al.  Immune suppression in healthy carriers of adult T-cell leukemia retrovirus (HTLV-I): impairment of T-cell control of Epstein-Barr virus-infected B-cells. , 1987, Japanese journal of cancer research : Gann.